| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8218704 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 7 Pages |
Abstract
HDR-IORT is a well-tolerated component of multimodality therapy for pediatric sarcoma, allowing additional local treatment while reducing external beam exposure. Taking clinical considerations into account, doses between 8-12 Gy are appropriate for HDR-IORT in patients â¤6 years of age.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Michael R. MD, PhD, William Y. MD, Michael P. MD, Leonard H. MD, Alexander J. MD, Heather MD, Michael J. MD, Suzanne L. MD,